According to Dr. Evangelos Michelakis of The University of Alberta Canada DCA, an inexpensive compound may cure tumorous cancers. Dichloroacetic acid, often abbreviated DCA, is a chemical compound. Salts of DCA have been studied as potential drugs because they inhibit an enzyme associated with some diseases like cancer.
DCA works by reviving the energy producing components of living cells causing them to work normally again and triggering cancer cells to commit suicide. There have been clinical trials of DCA for the past seven years. Preliminary studies have shown DCA can slow the growth of certain tumors in animals and in test tube trials. While some in the medical field believe that available evidence does not support the use of DCA for cancer treatment at this time. Many doctors feel it’s potential does warrant study in clinical trials. DCA has been associated with tumor regression and had a good safety profile. DCA side effects have been minimal when used in low doses over a short period of time.
Since DCA was discovered in 1864, it is not patentable (making it inexpensive to purchase) but the clinical trials needed to get a drug recognized and authorized for sale in a major nation can easily cost hundreds of millions of dollars. Drug companies are not interested in paying for trials for a drug they can’t get a patent on (because there is no real way to recoup the costs of the trial with profits since any company can make and sell DCA) so universities have been conducting clinical trials.
The promise of a cheap cure for cancer has caused some people to self medicate but doctors warn against that as there are health risks to those who are doing so outside of a clinical trial. Perhaps at least one nation’s Government can take on the costs of the trials so their citizens could reap the benefits from DCA.
In True Faith,
The Prophet of Life
An AIDS Cure Found?
Copyright 2013 Love Force International Publishing Company. All Rights Reserved.